Showing results (81-90 of 152) with videos related to
Sort By:
Pageof 16
Plos Pathogens|April 14, 2018
A novel mechanism of RNase L inhibition: Theiler's virus L* protein prevents 2-5A from binding to RNase LMelissa Drappier, Babal Kant Jha, Sasha Stone, et al.Antimicrobial Agents and Chemotherapy|May 21, 2014
Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronavirusesAdeyemi O Adedeji, Kamalendra Singh, Ademola Kassim, et al.Journal of Structural and Functional Genomics|October 8, 2005
Enhanced expression and purification of membrane proteins by SUMO fusion in Escherichia coliXun Zuo, Shuisen Li, John Hall, et al.Oncotarget|October 31, 2015
RNase L is a negative regulator of cell migrationShuvojit Banerjee, Geqiang Li, Yize Li, et al.Journal of Virology|August 21, 2020
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 <i>In Vitro</i> and SARS-CoV <i>In Vivo</i>Stuart Weston, Christopher M Coleman, Robert Haupt, et al.Journal of Virology|January 30, 2009
Organ-specific attenuation of murine hepatitis virus strain A59 by replacement of catalytic residues in the putative viral cyclic phosphodiesterase ns2Jessica K Roth-Cross, Helen Stokes, Guohui Chang, et al.Journal of Virology|January 16, 2015
The nsp1, nsp13, and M proteins contribute to the hepatotropism of murine coronavirus JHM.WURong Zhang, Yize Li, Timothy J Cowley, et al.Mbio|July 3, 2014
Murine AKAP7 has a 2',5'-phosphodiesterase domain that can complement an inactive murine coronavirus ns2 geneElona Gusho, Rong Zhang, Babal K Jha, et al.RNA (New York, N.Y.)|September 29, 2020
Physiologic RNA targets and refined sequence specificity of coronavirus EndoURachel Ancar, Yize Li, Eveline Kindler, et al.Journal of Virology|April 17, 2015
Structural basis for 2'-5'-oligoadenylate binding and enzyme activity of a viral RNase L antagonistKristen M Ogden, Liya Hu, Babal K Jha, et al.Pageof 16